mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.04 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.04 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |